Modulation of neurodegeneration by molecular chaperones

Nature Reviews Neuroscience

Volumn 6, Issue 1, 2005, Pages 11-22

  Muchowski, Paul J ^a,b   Wacker, Jennifer L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ANDROGEN RECEPTOR; CHAPERONE; POLYGLUTAMINE; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; SPINAL MUSCULAR ATROPHY; SPINOCEREBELLAR DEGENERATION;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS;

ANIMALIA;

EID: 11144243412     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1587     Document Type: Review

References (124)

1. Muchowski, P. J. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron 35, 9-12 (2002).
2. Soti, C. & Csermely, P. Chaperones and aging: role in neurodegeneration and in other civilizational diseases. Neurochem. Int. 41, 383-389 (2002).
3. Anfinsen, C. B. Principles that govern the folding of protein chains. Science 181, 223-230 (1973).
4. Ellis, R. J. Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr. Opin Struct. Biol. 11, 114-119 (2001).
5. Hartl, F. U. & Hayer-Hartl, M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295, 1852-1858 (2002).
6. Lindquist, S. The heat-shock response. Annu. Rev. Biochem. 55, 1151-1191 (1986).
7. Ballinger, C. A. et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol. 19, 4535-1545 (1999).
8. Jiang, J. et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J. Biol. Chem. 276, 42938-42944 (2001).
9. Luders, J., Demand, J. & Hohfeld, J. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J. Biol. Chem. 275, 4613-4617 (2000).
10. Cuervo, A. M. & Dice, J. F. Lysosomes, a meeting point of proteins, chaperones, and proteases. J. Mol. Med. 76, 6-12 (1998).
11. Dobson, C. M. Protein folding and misfolding. Nature 426, 884-890 (2003).
12. Katzman, R. et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23, 138-144 (1988).
13. Terry, R. D., Peck, A., DeTeresa, R., Schechter, R. & Horoupian, D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184-192 (1981).
14. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acts Neuropathol. (Berl.) 82, 239-259 (1991).
15. Tompkins, M. M. & Hill, W. D. Contribution of somal Lewy bodies to neuronal death. Brain Res. 775, 24-29 (1997).
16. Waelter, S. et al. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell 12, 1393-1407 (2001).
17. Muchowski, P. J., Ning, K., D'Souza-Schorey, C. & Fields, S. Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment. Proc. Natl Acad. Sci. USA 99, 727-732 (2002).
18. Taylor, J. P. et al. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12, 749-757 (2003).
19. Arrasate, M., Mitra, S. M, Schweitzer, E. S., Segal M. R & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810 (2004). An elegant study showing that inclusion body formation enhances the survival of striatal neurons that express mutant huntingtin fragments.
20. Caughey, B. & Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267-298 (2003).
21. Walsh, D. M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539 (2002). The first study to indicate that administration of Aβ oligomers to rats could recapitulate important pathological features of AD in vivo.
22. Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003). This study shows that spherical oligomers formed by several distinct amyloidogenic proteins share a common structural epitope that is recognized by an oligomer-specific antibody.
23. Sherman, M. Y. & Goldberg, A. L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29, 15-32 2001).
24. Stenoien, D. L., Mielke, M. & Mancini, M. A. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nature Cell Biol. 4, 806-810 (2002).
25. Chai, Y., Shao, J., Miller, V. M., Williams, A. & Paulson, H. L. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc. Natl Acad. Sci. USA 99, 9310-9315 (2002).
26. Kim, S., Nollen, E. A., Kitagawa, K., Bindokas, V. P. & Morimoto, R. I. Polyglutamine protein aggregates are dynamic. Nature Cell Biol. 4, 826-831 (2002). The first report that HSP70 interacts dynamically with mutant polyglutamine inclusions in vitro, rather than being sequestered.
27. Broquet, A. H., Thomas, G., Masliah, J., Trugnan, G. & Bachelet, M. Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J. Biol. Chem. 278, 21601-21606 (2003).
28. Kakimura, J. et al. Microglial activation and amyloid-β clearance induced by exogenous heat-shock proteins. FASEB J. 16, 601-603 (2002).
29. Kakimura, J., Kitamura, Y., Taniguchi, T., Shimohama, S. & Gebicke-Haerter, P. J. Bip/GRP78-induced production of cytokines and uptake of amyloid-β(1-42) peptide in microglia. Biochem. Biophys. Res. Commun. 281, 6-10 (2001).
30. Hsia, A. Y. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl Acad. Sci. USA 96, 3228-3233 (1999).
31. Chui, D. H. et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nature Med. 5, 560-564 (1999).
32. Moechars, D. et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483-6492 (1999).
33. Kumar-Singh, S. et al. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol. Dis. 7, 9-22 (2000).
34. Cordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M. & Turner, A. J. Exclusively targeting β-secretase to upid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein. Proc. Natl Acad. Sci. USA 100, 11735-11740 (2003).
35. Chyung, A. S., Greenberg, B. D., Cook, D. G., Doms, R. W. & Lee, V. M. Novel β-secretase cleavage of β-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells. J. Cell Biol. 138, 671-680 (1997).
36. Cook, D. G. et al. Alzheimer's A β(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med. 3, 1021-1023 (1997).
37. Pasternak, S. H. et al. Presenilin-1, nicastrin, amyloid precursor protein, and γ-secretase activity are colocalized in the lysosomal membrane. J. Biol. Chem. 278, 26687-26694 (2003).
38. Yang, Y., Turner, R. S., & Gaut, J. R. The chaperone BIP/GRP78 binds to amyloid precursor protein and decreases Aβ40 and Aβ42 secretion. J. Biol. Chem. 273, 25552-25555 (1998).
39. Magrane, J., Smith, R. C., Walsh, K. & Querfurth, H. W. Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed β-amyloid in neurons. J. Neurosci. 24, 1700-1706 (2004). This study reports that virally mediated overexpression of HSP70 successfully rescues neurons from the toxic effects of intracellular Aβ accumulation.
40. McCracken, A. A. & Brodsky, J. L. Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). Bioessays 25, 868-877 (2003).
41. Stege, G. J. et al. The molecular chaperone αB-crystallin enhances amyloid β neurotoxicity. Biochem. Biophys. Res. Commun. 262, 152-156 (1999).
42. Shimura, H., Miura-Shimura, Y. & Kosik, K. S. Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphoryiated tau and enhanced cell survival. J. Biol. Chem. 279, 17957-17962 (2004).
43. Dou, F. et el. Chaperones increase association of tau protein with microtubules. Proc. Natl Acad. Sci. USA 100, 721-726 (2003). In this study, both RNAi and drug-induced chaperone overexpression were used to show that HSP70 and HSP90 Chaperones maintain tau in a soluble, functional conformation and concomitantly prevent tau aggregation.
44. Petrucelli, L. et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703-714 (2004).
45. Shimura, H., Schwartz, D., Gygi, S. P. & Kosik, K. S. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279, 4869-4876 (2004). This study establishes that the cooperative activity of the E3-ligase CHIP and HSP70 decreases taumediated toxicity by facilitating the ubiquitylation of pathogenic, phosphorylated tau and causing its degradation or sequestration into an insoluble compartment.
46. McLean, P. J., Kawamata, H. & Hyman, B. T. α-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104, 901-912 (2001).
47. McLean, P. J. et al. TorsinA and heat shock proteins act as molecular chaperones: suppression of α-synuclein aggregation. J. Neurochem. 83, 846-854 (2002).
48. Klucken, J., Shin, Y., Masliah, E., Hyman, B. T. & McLean, P. J. Hsp70 reduces α-synuclein aggregation and toxicity. J. Biol. Chem. 279, 25497-25502 (2004).
49. Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. & Sulzer, D. Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy Science 305, 1292-1595 (2004).
50. Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M. & Bonini, N.M. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865-868 (2002). The first study to show a neuroprotective effect of HSP70 in an In vivo model of PD.
51. Auluck, P. K. & Bonini, N. M. Pharmacological prevention of Parkinson disease in Drosophila. Nature Med. 8, 1185-1186 (2002).
52. Morimoto, R. I. & Santoro, M. G. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nature Biotechnol. 16, 833-838 (1998).
53. Batulan, Z. et al. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J. Neurosci. 23, 5789-5798 (2003).
54. Lowenstein, D. H., Chan, P. H. & Miles, M. F. The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity. Neuron 7, 1053-1060 (1991).
55. Bechtold, D. A., Rush, S. J. & Brown, I. R. Localization of the heat-shock protein Hsp70 to the synapse following hyperthermic stress in the brain. J. Neurochem. 74, 641-646 (2000).
56. Bruening, W. et al. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem. 72, 693-699 (1999).
57. Shinder, G. A., Lacourse, M. C., Minotti, S. & Durham, H. D. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 276, 12791-12796 (2001).
58. Takeuchi, H. et al. Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1. Brain Res. 949, 11-22 (2002).
59. Chai, Y., Koppenhafer, S. L., Bonini, N. M. & Paulson, H. L. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J. Neurosci. 19, 10338-10347 (1999).
60. Jana, N. R., Tanaka, M., Wang, G. & Nukina, N. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9, 2009-2018 (2000).
61. Kobayashi, Y. & Sobue, G. Protective effect of chaperones on polyglutamine diseases. Brain Res. Bull. 56, 165-168 (2001).
62. Wyttenbacn, A. et al. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11, 1137-1151 (2002).
63. Zhou, H., Li, S. H. & Li, X. J. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation. J. Biol. Chem. 276, 48417-48424 (2001).
64. Krobitsch, S. & Lindquist, S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl Acad Sci. USA 97, 1589-1594 (2000).
65. Meriin, A. B. et al. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 157, 997-1004 (2002).
66. Muchowski, P. J. et al. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc. Natl Acad. Sci. USA 97, 7841-7846 (2000). The first report showing that the major effect of HSP70 and HSP40 on polyQ aggregation is to enhance polyQ solubility.
67. Hsu, A. L., Murphy, C. T. & Kenyon, C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300, 1142-1145 (2003).
68. Warrick, J. M. et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939-949 (1998).
69. Warrick, J. M. et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nature Genet. 23, 425-428 (1999). The first study to establish that in D. melanogaster endogenous HSP70 offers limited protection against mutant polyglutamine toxicity, and overexpression significantly suppresses degeneration.
70. Chan, H. Y., Warrick, J. M., Gray-Board, G. L., Paulson, H. L. & Bonini, N. M. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet 9, 2811-2820 (2000).
71. Gunawardena, S. et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40, 25-40 (2003).
72. Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506 (1996).
73. Hansson, O. et al. Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression. Brain Res. 970, 47-57 (2003).
74. Hay, D. G. et al. Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum. Mol. Genet. 13, 1389-1405 (2004).
75. Cummings, C. J. et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet 10, 1511-1518 (2001). The first report of HSP70 overexpression causing a significant amelioration of disease pathology and phenotypic improvemenl in a mouse model of polyQ disease.
76. Adachi, H. et al. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 23, 2203-2211 (2003).
77. Fernandez-Funez, P. et al. Identification of genes that modify ataxin-1 -induced neurodegeneration. Nature 408, 101-106 (2000).
78. Kazemi-Esfarjani, P. & Benzer, S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837-1840 (2000).
79. Willingham, S., Outeiro, T. F., DeVit, M. J., Lindquist, S. L. & Muchowski, P. J. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein. Science 302, 1769-1772 (2003). This genetic screen showed that the genes that enhance toxicity of the mutant huntingtin fragment in yeast cluster in the functionally related cellular processes of response to stress, protein folding and ubiquitin-dependent protein catabolism.
80. Nollen, E. A. et al. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl Acad. Sci. USA 101, 6403-6408 (2004).
81. Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M. & Muchowski, P. J. Hsp70 and Hsp40 attenuate spherical and annular polyglutamine oligomers by monomer partitioning. Nature Struct. Mol. Biol. (in the press). The first report to show that chaperones prevent accumulation of spherical and annular oligomeric assemblies by a mutant huntingtin fragment.
82. Schaffar, G. et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15, 95-105 (2004). This study shows that HSP70/HSP40 prevent an intramolecular conformational change in a mutant huntingtin fragment that might correlate with toxicity.
83. Collins, S. R., Douglass, A., Vale, R. D. & Weissman, J. S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol. 2, E321 (2004). This study shows that the kinetics of in vitro amyloid fibril polymerization can be best explained by a mechanism that involves monomer addition.
84. Hottiger, T., De Virgilio, C., Hall, M. N., Boller, T. & Wiemken, A. The role of trehalose synthesis for the acquisition of thermotolerance in yeast. II. Physiological concentrations of trehalose increase the thermal stability of proteins in vitro. Eur. J. Biochem. 219, 187-193 (1994).
85. Tatzeit, J., Prusiner, S. B. & Welch, W. J. Chemical chaperon es interfere with the formation of scrapie prion protein. EMBO J. 15, 6363-6373 (1996).
86. Wang, A. & Bolen, D. W. A naturally occurring protective system in urea-rich cells: mechanism of osmolyte protection of proteins against urea denaturation. Biochemistry 36, 9101-9108 (1997).
87. Attfield, P. V. Trehalose accumulates in Saccharomyces cerevisiae during exposure to agents that induce heat shock response. FEBS Lett. 225, 259-263 (1987).
88. Singer, M. A. & Lindquist, S. Multiple effects of trehalose on protein folding in vitro and in vivo. Mol. Cell 1, 639-648 (1998).
89. Tanaka, M. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nature Med. 10, 148-154 (2004).
90. Mosser, D. D. & Morimoto, R. I. Molecular chaperones and the stress of oncogenesis. Oncogene 23, 2907-2918 (2004).
91. Ananthan, J., Goldberg, A. L. & Voellmy, R. Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes. Science 232, 522-524 (1986).
92. Zou, J., Quo, Y., Guettouche, T., Smith, D. F. & Voellmy, R. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94, 471-480 (1998).
93. Prodromou, C. et al. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90, 65-75 (1997).
94. Roe, S. M. et al. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 42, 260-266 (1999).
95. Hargitai, J. et al. Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1. Biochem. Biophys. Res. Commun. 307, 689-695 (2003).
96. Kieran, D. et al. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nature Med. 10, 402-405 (2004). The first study to show that pharmacological induction of the heat shock response is protective against neurodegeneration in a mouse model of ALS.
97. Sanchez, Y. & Lindquist, S. L. HSP104 required for induced thermotolerance. Science 248, 1112-1115 (1990).
98. Lindquist, S. & Kim, G. Heat-shock protein 104 expression is sufficient for thermotolerance in yeast. Proc. Natl Acad Sci. USA 93, 5301-5306 (1996).
99. Shorter, J. & Lindquist, S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304, 1793-1797 (2004).
100. Smith, D. F., Whitesell, L. & Katsanis, E. Molecular chaperones: biology and prospects for pharmacological intervention. Pharmacol. Rev. 50, 493-514 (1998).
101. Young, J. C. & Hartl, F. U. Chaperones and transcriptional regulation by nuclear receptors. Nature Struct. Biol. 9, 640-642 (2002).
102. Bukau, B. & Harwich, A. L. The Hsp70 and Hsp60 chaperone machines. Cell 92, 351-366 (1998).
103. Tavaria, M., Gabriele, T., Kola, I. & Anderson, R. L. A hitchhiker's guide to the human Hsp70 family. Cell Stress Chaperones 1, 23-28 (1996).
104. Fink, A. L. Chaperone-mediated protein folding. Physiol. Rev. 79, 425-449 (1999).
105. Wall, D., Zylicz, M. & Georgopoulos, C. The conserved G/F motif of the DnaJ chaperone is necessary for the activation of the substrate binding properties of the DnaK chaperone. J. Biol. Chem. 270, 2139-2144 (1995).
106. Wall, D., Zylicz, M. & Georgopoulos, C. The NH2-terminal 108 amino acids of the Escherichia coli DnaJ protein stimulate the ATPase activity of DnaK and are sufficient for lambda replication. J. Biol. Chem. 269, 5446-5451 (1994).
107. Minami, Y., Hohfeld, J., Ohtsuka, K. & Hartl, F. U. Regulation of the heat-shock protein 70 reaction cycle by the mammalian DnaJ homolog, Hsp40. J. Biol. Chem. 271, 19617-19624 (1996).
108. Hartl, F. U. Molecular chaperones incellular protein folding. Nature 381, S71-S79 (1996),
109. Cheetham, M. E. & Caplan, A. J. Structure, function and evolution of DnaJ: conservation and adaptation of chaperone function. Cell Stress Chaperones 3, 28-36 (1998).
110. Horwitz, J. α-crystallin can function as a molecular chaperone. Proc. Natl Acad. Sci. USA 89, 10449-10453 (1992).
111. Clark, J. I. & Muchowski, P. J. Small heat-shock proteins and their potential role in human disease. Curr. Opin. Struct. Biol. 10, 52-59 (2000).
112. Litt, M. et al. Autosomal dominant congenital cataract associated with a missense mutation in the human α crystallin gene CRYAA. Hum. Mol. Genet 7, 471-474 (1998).
113. Fardeau, M. et al. Familial myopathy with desmin storage seen as a granulo-filamentar, electron-dense material with mutation of the αB-cristallin gene. Rev. Neurol. (Paris) 156, 497-504 (2000).
114. Vicart, P. et al. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nature Genet 20, 92-95 (1998).
115. Evgrafov, O. V. et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nature Genet. 36, 602-606 (2004).
116. Irobi, J. et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nature Genet. 36, 597-601 (2004).
117. Hansen, J. J. et al. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet 70, 1328-1332 (2002).
118. Barra, J. M., Broadley, S. A., Schaffar, G. & Hart, F. U. Roles of motecularchaperones in protein misfolding diseases. Semin. Cell Dev. Biol. 15, 17-29 (2004).
119. Hamos, J. E. et al. Expression of heat shock proteins in Alzheimer's disease. Neurology 41, 345-350 (1991).
120. Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T. & Kato, K. α B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J. Neurol. Sci. 119, 203-208 (1993).
121. Renkawek, K., Bosman, G. J. & de Jong, W. W. Expression of small heat-shock protein HSP27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol. (Berl.) 87, 511-519 (1994).
122. Nemes, Z., Devreese, B., Steinert, P. M., Van Beeumen, J. & Fesus, L. Cross-linking of ubiqurtin, HSP27, parkin, and α-synuclein by γ-glutamyl-ε-lysine bonds in Alzheimer's neurofibrillary tangles. FASEB J. 18, 1135-1137 (2004).
123. Watanabe, M. et al. Histological evidence of protein aggregation in mutant SOD1 transgenb mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 8, 933-941 (2001).
124. Cummings, C. J. et al. Chaperone suppression of aggregation and altered subcellular proteasome localeation imply protein misfolding in SCA1. Nature Genet. 19, 148-154 (1998).